# 119-hres-803: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

119-hres-803, Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes., is a 119th Congress bill sponsored by Rep. Rose, John W. [R-TN-6] (R-TN); status introduced (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hres-803
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hres-803
- Congress: 119
- Title: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
- Status: introduced
- Introduced: 2025-10-10
- Sponsor: Rep. Rose, John W. [R-TN-6] (R-TN)
- Cosponsors: 11
- Policy area: Health
- Touches household money: no
- Last recorded action: 2026-04-21

## Summary

**Reevaluate the safety of all chemical abortion drugs.** This resolution would urge the FDA Director to conduct a full safety review and to publicly release real-world outcomes and complication data for these drugs. - Women and girls: it raises concerns about physical and emotional harm and cites independent research claiming serious complications are about 22 times higher than currently reported. - Patients and providers: it notes chemical abortions now make up more than half of all abortions in the United States and that many prescribing providers receive taxpayer funding. - FDA and regulators: it would ask the FDA to reevaluate every chemical abortion drug and to publish a full safety review that includes real-world outcomes and complications. - States and laws: it highlights the FDA's September 30, 2025 approval of a generic mifepristone and asserts that greater availability could increase abortions and undermine state pro-life laws.

## Cosponsors (11)

- Rep. Harshbarger, Diana [R-TN-1] (R-TN), 2025-10-10T00:00:00.000Z
- Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA), 2025-10-10T00:00:00.000Z
- Rep. LaMalfa, Doug [R-CA-1] (R-CA), 2025-10-10T00:00:00.000Z
- Rep. Biggs, Sheri [R-SC-3] (R-SC), 2025-10-10T00:00:00.000Z
- Rep. Moore, Barry [R-AL-1] (R-AL), 2025-10-10T00:00:00.000Z
- Rep. Hageman, Harriet M. [R-WY-At Large] (R-WY), 2025-10-10T00:00:00.000Z
- Rep. Grothman, Glenn [R-WI-6] (R-WI), 2025-10-10T00:00:00.000Z
- Rep. Aderholt, Robert B. [R-AL-4] (R-AL), 2025-10-17T00:00:00.000Z
- Rep. Harris, Andy [R-MD-1] (R-MD), 2025-10-28T00:00:00.000Z
- Rep. Guest, Michael [R-MS-3] (R-MS), 2025-11-04T00:00:00.000Z
- Rep. Cline, Ben [R-VA-6] (R-VA), 2025-11-04T00:00:00.000Z

## Related bills

- 119-hr-21: Born-Alive Abortion Survivors Protection Act
- 119-hr-7: No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025
- 119-hr-703: Main Street Tax Certainty Act
- 119-hr-425: Repealing Big Brother Overreach Act
- 119-hr-569: Birthright Citizenship Act of 2025
- 119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025

## Sources
- [119-hres-803 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-resolution/803)

## Related
- [119-hr-21: Born-Alive Abortion Survivors Protection Act](https://policyrisk.com/legislation/119-hr-21)
- [119-hr-7: No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of…](https://policyrisk.com/legislation/119-hr-7)
- [119-hr-703: Main Street Tax Certainty Act](https://policyrisk.com/legislation/119-hr-703)
- [119-hr-425: Repealing Big Brother Overreach Act](https://policyrisk.com/legislation/119-hr-425)
- [119-hr-569: Birthright Citizenship Act of 2025](https://policyrisk.com/legislation/119-hr-569)
- [119-hr-38: Constitutional Concealed Carry Reciprocity Act of 2025](https://policyrisk.com/legislation/119-hr-38)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hres-803 (as of 2026-04-21).